MyHomeDoctor - Suivi des patients après une chirurgie ambulatoire

The latest studies inserted

Kusajili is updated regularly with data from the following sources: ACTRN, EU Clinical Trials Register, GlaxoSmithKline (GSK) Clinical Study Register, Clinical Trials Search Portal provides, ISRCTN, JPRN, ClinicalTrials - NCT, Pfizer, Takeda, Pubmed.

Spotlight on 3 studies

Regularly we prefer 3 studies to help the inclusion of patients.

Immunomodulation of EA-230 Following On-pump Coronary Artery Bypass Grafting (CABG)

EA-230 is a newly developed synthetic compound with anti-inflammatory properties, it is a linear tetrapeptide derived from the human chorionic gonadotropin hormone (hCG). Recently, its immunomodulatory effects in humans were confirmed in a phase I trial and an optimal dose was established. To establish this anti-inflammatory effect in a selected patient population and asses...

More information

Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer

The purpose of this study is to determine the safety and tolerability of rebastinib when combined with antitubulin therapy with paclitaxel or eribulin in patients with advanced breast cancer.

More information

Phase 1 Study of Anti-PD-L1 Monoclonal Antibody KN035 to Treat Locally Advanced or Metastatic Solid Tumors

This is an open label, dose escalation study to evaluate the safety and tolerability of KN035 in advanced and metastatic solid tumor.

More information


Kusajili is a protean search engine that addresses the need to simplify access to registers and patient inclusions.
Kusajili makes it possible to find in a few clicks, the numerous French and international trials referenced.
Kusajili, associated with MyHomeDoctor, facilitates multicenter clinical trials.
Docteur CRETON, Créateur de KUSAJILI

More information